Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...

Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide in 2025, a few months earlier than expected. The company expects to provide ...

Learn more Cats can lose weight safely with one of the best weight ... you'll need to convert the wet food values to a dry matter basis to compare the nutritional content. This means you remove ...

Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a big revenue increase Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound ...

Arne Slot insists he has no regrets over team selection as a much-changed Liverpool were knocked out of the FA Cup by Plymouth Argyle on Sunday. Slot made 10 changes in total from the side that ...

The VGChartz sales comparison series of articles are updated monthly and each one focuses on a different sales comparison using our estimated video game hardware figures. The charts include ...

Sales of Mounjaro were $3.53 billion, missing projections of $4.27 billion. Meanwhile, its Zepbound weight-loss drug grew by 52% against the previous quarter to $1.91 billion, also below expectations.

Zepbound is a subcutaneous injection that needs proper storage and handling during travel. There are ways you can travel with Zepbound to ensure it remains safe and effective to use. Zepbound ...

This could represent a real problem. There are separate growth charts for weight, height, and head circumference. These simply represent the average weight, height, or head circumference of a ...